Skip to content
healthcare.dev
Get a free key

Liothyronine Sodium

NDC 87063-082, Liothyronine Sodium, tablet, from ASCLEMED USA INC..

Product NDC
87063-082
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA200295
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-082 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM50 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
87063-082-0187063008201100 TABLET in 1 BOTTLE (87063-082-01)
87063-082-308706300823030 TABLET in 1 BOTTLE (87063-082-30)
87063-082-608706300826060 TABLET in 1 BOTTLE (87063-082-60)
87063-082-908706300829090 TABLET in 1 BOTTLE (87063-082-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/26cf6872-f4d4-41dd-8957-a000f13efbb3

Use it

Look up 87063-082 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-082 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-082. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.